Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
181 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Blood Platelet Disorders"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Thrombocytopathy in Gaucher Disease Patients
Conditions: Gaucher Disease;   Thrombocytopathy
Intervention:
2 Recruiting Relationship Between Level of Hemoglobin A1c and Platelet Function in Patients Undergoing Cardiac Surgery
Conditions: Diabetes Mellitus;   Complication of Coronary Artery Bypass Graft;   Blood Platelet Disorders
Intervention:
3 Not yet recruiting Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
Condition: Inherited Platelet Disorders
Intervention: Other: Blood collection for platelet protein samples
4 Not yet recruiting Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy
Conditions: Hemorrhage, Surgical;   Hip Replacement, Total;   Thrombocytopathy
Interventions: Drug: Gelofusine® B. Braun;   Drug: Ringerfundin ® B. Braun
5 Unknown  Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
6 Recruiting Eltrombopag for Inherited Thrombocytopenias
Condition: Inherited Platelet Disorder
Intervention: Drug: Eltrombopag
7 Not yet recruiting Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
Conditions: ITP;   Croticosteroid Therapy
Interventions: Drug: High dose Dexamethasone pulses;   Drug: Prednisone
8 Recruiting Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
Conditions: Polycythemia Vera;   Thrombocythemia, Essential
Intervention: Drug: No cytoreductive vs cytoreductive drugs
9 Recruiting Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Thrombocytopenia
Interventions: Drug: Eltrombopag/Revolade;   Other: Placebo
10 Recruiting Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter
Conditions: Thrombopenia;   Central Venous Catheter Placement
Intervention: Procedure: Platelets transfusion
11 Recruiting Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Condition: Hemolytic Uremic Syndrome
Intervention: Biological: Extra blood draw samples
12 Recruiting Myeloproliferative Neoplastic Diseases Observatory From Brest
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Primary Myelofibrosis
Intervention:
13 Recruiting Immune Thrombocytopenia in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Other: No intervention
14 Not yet recruiting Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)
Condition: Acquired Thrombotic Thrombocytopenic Purpura
Intervention: Biological: caplacizumab
15 Recruiting Cytopenias Autoimmune: Midi-Pyrenees Register
Condition: Immune Thrombocytopenia
Intervention: Other: no specific intervention
16 Recruiting Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
Condition: Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: Eltrombopag
17 Recruiting Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Conditions: Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase;   Primary Myelofibrosis
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis
18 Not yet recruiting Molecular and Clinical Profile of Von Willebrand Disease in Spain
Condition: Von Willebrand Disease
Intervention: Genetic: VWF gene analysis
19 Recruiting Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Romiplostim;   Drug: Placebo
20 Recruiting Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Intervention: Drug: Romiplostim

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years